MedPath

Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension

Phase 4
Completed
Conditions
Hypertension
Interventions
Registration Number
NCT00741078
Lead Sponsor
Gachon University Gil Medical Center
Brief Summary

The investigators hypothesized combination therapy would be superior to monotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Hypertension
Exclusion Criteria
  • Chronic renal disease
  • Severe hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
atorvastatin, amlodipinestatin, amlodipine-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gil Medical Center

🇰🇷

Incheon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath